O. A. UYAROĞLU Et Al. , "Comparison of Favipiravir to Hydroxychloroquine Plus Azithromycin in the Treatment of Patients with Non-critical COVID-19: A Single-center, Retrospective, Propensity Score-matched Study," Acta Medica , vol.53, no.1, pp.73-82, 2022
UYAROĞLU, O. A. Et Al. 2022. Comparison of Favipiravir to Hydroxychloroquine Plus Azithromycin in the Treatment of Patients with Non-critical COVID-19: A Single-center, Retrospective, Propensity Score-matched Study. Acta Medica , vol.53, no.1 , 73-82.
UYAROĞLU, O. A., SÖNMEZER, M. Ç., TELLİ DİZMAN, G., ÇALIK BAŞARAN, N., KARAHAN, S., & UZUN, Ö., (2022). Comparison of Favipiravir to Hydroxychloroquine Plus Azithromycin in the Treatment of Patients with Non-critical COVID-19: A Single-center, Retrospective, Propensity Score-matched Study. Acta Medica , vol.53, no.1, 73-82.
UYAROĞLU, OĞUZ Et Al. "Comparison of Favipiravir to Hydroxychloroquine Plus Azithromycin in the Treatment of Patients with Non-critical COVID-19: A Single-center, Retrospective, Propensity Score-matched Study," Acta Medica , vol.53, no.1, 73-82, 2022
UYAROĞLU, OĞUZ A. Et Al. "Comparison of Favipiravir to Hydroxychloroquine Plus Azithromycin in the Treatment of Patients with Non-critical COVID-19: A Single-center, Retrospective, Propensity Score-matched Study." Acta Medica , vol.53, no.1, pp.73-82, 2022
UYAROĞLU, O. A. Et Al. (2022) . "Comparison of Favipiravir to Hydroxychloroquine Plus Azithromycin in the Treatment of Patients with Non-critical COVID-19: A Single-center, Retrospective, Propensity Score-matched Study." Acta Medica , vol.53, no.1, pp.73-82.
@article{article, author={OĞUZ ABDULLAH UYAROĞLU Et Al. }, title={Comparison of Favipiravir to Hydroxychloroquine Plus Azithromycin in the Treatment of Patients with Non-critical COVID-19: A Single-center, Retrospective, Propensity Score-matched Study}, journal={Acta Medica}, year=2022, pages={73-82} }